Debut at Pet Fair Asia 2026: Innovative Mucosal‑Absorption Formulas Empower a New Ecosystem for Refined Pet Care

Recently, the 28th Pet Fair Asia grandly opened at Shanghai New International Expo Centre. As a flagship pet‑industry event across the Asia‑Pacific region, this edition centers on new‑product launches, technological innovation and industrial upgrading. It brings together more than 2,600 premium global pet‑industry enterprises to showcase cutting‑edge technologies, innovative dosage forms and refined pet‑care solutions, steering the industry toward high‑quality and sophisticated development.

This is not our first major appearance at industrial expos. Previously, we presented our innovative pet fast‑dissolving oral films at leading domestic trade shows including Shenzhen Pet Fair and Guangzhou Pet Fair. We have also expanded into overseas markets by participating in top‑tier international pet expos such as Global Pet Expo in Orlando, the Las Vegas Pet Products Expo and the Nuremberg Exhibition in Germany, continuously demonstrating our technologies and product strengths for pet fast‑dissolving oral films to global audiences.

For Pet Fair Asia 2026, we exhibited jointly with our strategic partner Zhejiang Qizhen Technology Co., Ltd. A professional manufacturer of complete sets of equipment for fast‑dissolving oral films, Zhejiang Qizhen Technology devotes itself to the R&D and production of intelligent full‑set equipment for film forming, molding and packaging, with rich practical experience and profound technical accumulation in film‑form processing and equipment implementation. Our company takes charge of formula research, finished‑product development and market‑oriented roll‑out for pet fast‑dissolving oral films, while Zhejiang Qizhen Technology provides professional equipment support. Together, we unveiled our groundbreaking mucosal‑absorption dosage forms for pets. Boasting advantages of ease‑of‑use, high efficiency and broad adaptability, our products align closely with the expo’s core themes of technological innovation and industrial upgrading, enabling a successful professional showcase of fast‑dissolving oral‑film technologies and novel dosage forms.

As pet‑raising concepts evolve nationwide, refined, science‑driven and convenient pet care has become a mainstream industry trend. Moving past traditional single‑format products, pet health‑care goods are iterating toward lightweight design, strong adaptability and effortless administration. Compared with conventional tablets, powders and pastes, pet fast‑dissolving oral films represent a groundbreaking innovation in pet healthcare. They dissolve instantly upon contact with the oral cavity, with no need for force‑feeding, water or other delivery aids. This effectively addresses long‑standing industry pain points including pet food refusal, medication resistance and stress responses. Suitable for daily care and health conditioning for dogs and cats of all ages, these films balance safety and practicality and perfectly satisfy core demands of modern pet owners.

Our debut at Pet Fair Asia Shanghai marks a key public industry presentation of our pet fast‑dissolving oral‑film technology. During the show, our booth drew heavy foot traffic from distributors, channel partners, industry experts and avid pet owners, who stopped by for consultation and in‑depth exchanges. On‑site staff delivered comprehensive briefings and live demonstrations covering core technologies, formula merits, applicable scenarios, production processes and commercial strengths of fast‑dissolving oral films, intuitively highlighting improvements over conventional pet‑care products. Our offerings won wide recognition and high praise across the sector.

Through efficient collaboration with Zhejiang Qizhen Technology, we leveraged our strengths in end‑product R&D for pets alongside Qizhen Technology’s expertise in intelligent equipment manufacturing for oral films. We accomplished product display, technical popularization, industry dialogue, channel matching and industrial empowerment, fully illustrating the win‑win value of upstream‑downstream collaboration integrating “formula R&D plus intelligent equipment manufacturing”.

Our core R&D team consists of pharmaceutical‑background professionals, who are among China’s earliest pioneers researching fast‑dissolving oral‑film dosage forms, with over ten‑year experience in this field. Drawing on solid expertise and proven technical know‑how, the team has strategically entered the pet‑health sector. We have built robust in‑house capabilities covering independent R&D, formula iteration, large‑scale manufacturing and full‑chain quality control.

We focus on dosage‑form innovation and formula optimization for pets, and keep advancing R&D of pet nutritional supplements. Complying strictly with pets’ physiological traits and industrial production standards, we operate a rigorous end‑to‑end quality‑control system spanning raw‑material screening, formula development, process refinement and finished‑product inspection. Supported by robust research competence and mature supply chains, we deliver custom formula development, standardized mass production and differentiated product iteration to meet diverse and sophisticated market needs, and deliver safe, effective and innovative high‑quality solutions for pet health management.

While advancing in‑house research, we embrace the philosophy of open and win‑win industrial cooperation. We carry out deep joint development with high‑quality upstream raw‑material suppliers. Centering on advanced extraction techniques, high‑purity active ingredients and highly nutritive raw materials, we explore their application and transformation within innovative oral‑film products for pets. By combining premium raw‑material strengths with dosage‑form innovation, we bring more efficient and user‑friendly solutions to the pet nutritional‑supplement market. We sincerely invite qualified upstream raw‑material suppliers to connect and cooperate with us. By pooling mutual strengths, we can co‑develop innovative dosage‑form products for various functional purposes to address diversified pet‑health requirements.

Meanwhile, we provide flexible OEM and ODM services. Clients may select our mature formulas for mass production, or provide self‑sourced active ingredients or formulations. Our specialist team handles dosage‑form development and process implementation, converting varied active ingredients into convenient, high‑performance oral films and helping clients achieve fast product innovation and market launch. Positioned as a technical service provider and industrial enabler, we work with upstream and downstream partners to build an open, collaborative industrial ecosystem.

Participation in Pet Fair Asia serves not only as a major showcase for our innovative pet‑dosage‑form achievements, but also as a vital opportunity to engage with industry frontiers, connect high‑quality resources and capture market insights. Benefiting from the expo’s powerful industrial aggregation and new‑product‑launch platform, we connected extensively with upstream‑downstream stakeholders and exchanged cutting‑edge technical ideas. This further expanded our industry influence and market visibility, laying a solid foundation for future product commercialization, channel deployment and technical upgrading.

Moving forward, we will take Pet Fair Asia 2026 as a new starting point. We will keep investing in R&D and process optimization for fast‑dissolving oral‑film and other innovative dosage forms for pets, continuously refining formulas, expanding product portfolios and elevating product quality. Upholding the philosophy of science‑driven pet care and quality priority, and backed by robust in‑house R&D and manufacturing capacity, we will partner with industry peers to deliver premium pet‑health products and solutions. We aim to drive dosage‑form revolution and refined upgrading within China’s pet‑care industry, and keep empowering better lives for pets and their owners nationwide.